Venereal Disease*
ROBERT E. PETRES, M.D.
Instructor of Obstetrics and Gynecology,
Medical College of Virginia, Richmond, Virginia

Venereal disease, as we define it, is any disease
that is propagated or transmitted by sexual intercourse. Traditionally we have taught medical students that this included chancroid, lymphogranuloma
venereum, granuloma inguinale, gonorrhea, and
syphilis. Then we taught them enough to be able to
match up Donovan bodies, Frei test, Thayer Martin
media, and at that point we felt that we had pretty
much done our job. If we are to stick to the criteria
of diagnosis, I suggest we should also consider as
venereal diseases, Trichomonas, incomplete abortions, septic abortions, ectopic pregnancy, unwanted
pregnancy, crab lice, herpes simplex virus (type 2),
and carcinoma of the cervix. There is considerable
disparity among these conditions, but they all have
one thing in common: they reflect sexual activity.
Trichomonas, on the one hand, may represent sexual
activity several years in the past. The trichomonad
may lie asymptomatic in the female vagina or the
male urethra only to become apparent weeks, months,
or even years later. Squamous cell carcinoma, on the
other hand, is more like a scoreboard of total sexual
activity. Early intercourse, multiple partners, multiple pregnancies are all contributing factors in the
development of carcinoma of the cervix. Cervicitis
may lie somewhere in between these two extremes
and indeed be somewhat related to both.
Currently, gonorrhea is enjoying the most popularity, both in the literature and in the population.
We are unquestionably in the midst of an epidemic.
Last year in the United States, there were probably
two million cases of acute gonorrhea. We developed
forty thousand cases a week. One person gets gonorrhea every 15 seconds; every week sixty-five boys
returning from Viet Nam have the disease. Most of
these are under treatment. More than 25 % of patients with gonorrhea are less than 20 years of age;
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more than 50% of patients with gonorrhea are less
than 29 years of age. We are finding that the incidence in the general population is much higher
than previously supposed. Screening in OB and
GYN clinics across the country have consistently
come up with figures of between 5 and 10 percent
incidence of gonorrhea in those screened. It can be
safely said that one out of every ten girls between
the ages of 15 and 25 years of age harbors the
gonococcus.
The fact that we have had asymptomatic female carriers has been known for sometime. As a
matter of fact, probably 75% to 80% of women
with gonorrhea are totally asymptomatic. But they
are still infectious. They can still spread the disease.
We are just lately finding, much to our consternation, that there are asymptomatic male carriers as
well.
In the city of Norfolk, the Public Health Department made a series of studies on male contacts
of known female patients with gonorrhea. The result
was a raw incidence of 12% positive cultures in
asymptomatic men. If you corrected this by ruling
out the patients from whom cultures had been taken
during the incubation period, you would still have a
figure of 6%. In one uncontrolled and unpublished
series that was performed here by our Health
Department, they found 22 positive cultures in
asymptomatic men out of a group of 144 male contacts. I hasten to add that these 22 were not separated out as to whether or not they were in the
incubation period. With this large number of
asymptomatic patients in both the male and female
patient population, the obviously pressing problems
are to discover an adequate method of diagnosis
and to treat these people.
The first culture technique for the diagnosis
of gonorrhea was the use of chocolate agar. This
is plated with pus from the urethra, or the cervix,
or the anus, and then incubated under 10% of C02
at 37°C. With this classic type of culturing, sub77
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culturing must be carried out as well as sugar fermentations. It is frequently ten days before the
diagnosis can be made. Overgrowth is a problem,
particularly with proteus; since it may obliterate the
gonococcal culture.
The next improvement in diagnostic method
was the development of Thayer Martin media.
This media initially was chocolate agar with the addition of antibiotics, ristocetin, and polymixin. Lately
it is referred to as the VCN plate which contains
Vancomycin®, colistin, and nystatin for the suppression of the non-pathogenic bacteria and other contaminates such as staph, strep, and the gram negatives.
Thayer Martin media obviously has its advantages, but its chief disadvantage is that in order to
be effective it should be plated directly from the
patient, and as a result, the specimen frequently
loses viability on the way to the lab. Thayer Martin
media also has one small drawback due to its inhibitive factor, so that in terms of speed, the gonococcus may take up to three days to grow out,
whereas on chocolate agar it will frequently grow
out in 24 hours.
Carrying media prepared by Stuart is a liquid
in which the specimen can be immersed and shipped
to the lab. It is a non-nutrient media, and some cultures are lost because of this, but it has the advantage of protecting the gonococcus from oxidation.
Transgro has recently been developed. This is
a combination of a selective gonococcal media that
is also a transport media. It is a modified Thayer
Martin type media. It differs from the others in that
it is put up in a one-ounce medicine bottle with a
narrow neck. The media is layered on the side that
it forms a flat plate on the inside of the bottle
much like a blood culture bottle. Transgro contains
an increased amount of agar to make the culture
media more rigid for mailing, and it contains a higher
concentration of sugar. The bottle has an atmosphere
of 10% C02 under a rubber screw tip. It can be
plated directly from the patient at the time of examination and held at room temperature until ready
for mailing. It appears to be a very good media for
office practice; however, I would use with caution
any new technique, as laboratories will need time to
get used to it.
In addition to culturing methods for diagnosing
gonorrhea, the fluorescent antibody techniques have
been developed. The direct method is done by
plating the specimen on a glass slide, overlaying it
with fluorescent antibody, and then looking at it
under an ultraviolet microscope. The gonococcus
will fluoresce. Unfortunately, this will not reproduce
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the results obtainable with ordinary culture. It is
fast but its effectiveness is only in the range of 60%.
The delayed fluorescent antibody technique is much
better. It is done by first plating a chocolate agar
slant, allowing the specimen to grow on the slant
for 18 hours, and then removing the specimen to a
slide. During this time, the gonococcus will multiply
in such numbers that when it is visualized under an
ultraviolet light microscope one has a much higher
incidence of positive results. Thayer Martin media,
Transgro, chocolate agar, and the delayed fluorescent
antibody technique all have fairly comparable results of being positive in 75 % to 80% of known cases.
Who should be cultured? I think that we should
culture all prenatal patients because the incidence
of gonorrheal ophthalmia in newborns is on the rise.
In addition to prenatal patients, I am beginning to
believe that we should also culture for gonorrhea
everyone who is given a pack of birth control pills;
the reason being that anyone needing contraception
is obviously sexually active. And we should focus
particular attention on the 15- to 25-year-olds seeking
contraceptives, as they are the most susceptible
group.
Gonorrhea is a serious medical problem. Too
frequently we think of it as being a nuisance, but
it is more than that. Eighty percent of women are
asymptomatic, but we must remember that 10%
will develop salpingitis, and 3 % will be forever
sterile from the disease. The largest cause of infertility in our patient population is unquestionably
gonorrhea.
The treatment of choice remains penicillin, for
the time being anyway. The minimum treatment
for the female is 4.8 million units of procaine penicillin. I might interject here that in our practice,
we have hospitalized all patients suspected of having
salpingitis or those with systemic symptoms and
treated them with high levels of aqueous penicillin,
in addition to procaine penicillin. For years, much
more modest doses of the drug gave good cure
rates. I think the initial recommended dose of penicillin for gonorrhea by the Public Health Department was something like a single shot of 40
thousand units. Now, I am advocating 4.8 million
units because of the biologic change in the gonococcus. In 1947, the minimum lethal concentration
of penicillin was 0.004 units/ ml; in 1957, 0.1
units/ ml; in 1967, 1.0 units/ ml. This indicates a two
hundred and fifty-fold decrease in the sensitivity of
the gonococcus to penicillin. You can see by this
trend that the time is coming when we can no longer
use penicillin, because the capacity of the female
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buttock to receive procaine penicillin has been
reached. Much of the current emphasis in research
is on developing antibiotic alternatives for penicillin.
Tetracycline is usually considered a second-line
drug. Good results have also been achieved with
kanamycin, chloramphenicol, and erythromycin. The
combination of ampicillin and probenecid has
been used with success, and I might add that probenecid, which decreases excretion of penicillin,
may well be advised with the use of procaine penicillin. There is one study in Greenland using a combination of 5 million units of procaine penicillin and
one gram of probenecid. With this they have shown
that they are able to arrest the decreasing sensitivity of the gonococcus to penicillin.
Benzathine penicillin should never be used to
treat gonorrhea. A series of patients given 1.2 million units of benzathine penicillin were checked
24 hours later for circulating penicillin. More than
50% had less than 0.1 unitjml which is ten times
less than the amount necessary to treat gonorrhea,
and this may in fact have lead to the desensitization
of the disease to the drug.
If gonorrhea is the prima donna of venereal diseases, the spectre lurking in the shadows is syphilis.
We are not currently seeing a surge in the incidence
of syphilis; however, last year the total number of
cases did rise slightly although the rate of new cases
did not. Three hundred babies born last year had
congenital syphilis. Consider three hundred babies
with smallpox, syphilis being the great pox. Two
thousand people died last year of syphilis. There are
five hundred thousand patients in this country with
latent syphilis untreated or undertreated today. That
syphilis is not showing the same current increase as
gonorrhea is attributed by many to the fact that
syphilis may be aborted by the treatment of gonorrhea. One series has attempted to prove that the
current recommended dosage of procaine penicillin
will abort an incubating syphilis infection. This
series, begun in 1957, utilized as its criteria for
the cure of syphilis, the fact that the patients were
sero-negative and had no lesion of syphilis after
three months. I think that we should be a bit cautious about predicting whether or not these patients
are going to develop latent syphilis, and there are
physiologic reasons for having doubts. We know
that we can recover the spirochete from the anterior
chamber of the eye and from the cerebrospinal
fluid, and we also know that it is extremely difficult
to get therapeutic levels of penicillin into these
body fluids. A second physiologic fact that makes
me question this evidence . rs that penicillin
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will kill a spirochete only when the spirochete is
replicating. It replicates every 32 hours, but we can
assume that every spirochete is not killed the first
time. Procaine lasts 72 hours with good levels, so
the use of relatively short-acting penicillin like procaine as opposed to the long-acting benzathine leaves
one to wonder if all these syphilis infections are
cured or if the presenting symptoms are merely delayed or aborted altogether with the possibility of
latent syphilis developing.
There has been much speculation, but little
has been proven, about the increase in the incidence of venereal disease. It is very easy to say,
"Well, more people are doing more things more
often than they have been in the past." But it is
extremely difficult to prove. There is data to support this. Kinsey, in the 1940's, found that 20 %
of 20-year-old college women had had premarital
intercourse. Vance Packard in the 1960's found that
43 % of 20-year-old college females had had premarital intercourse. This increase shows, if it continues along these lines, that 60% of women born
this year will have had premarital intercourse by the
time they reach 20 years of age. And these are college women. If we add all women, we may well say
90% of women 20 years old will have had premarital intf"·.course. Now it is quite true that people
from high er socio-economic and educational levels
have more varied and imaginative sexual lives; however, people from lower socio-economic levels invariably start sooner. The incidence of gonorrhea in
the younger age group is high; but not higher now
than six years ago. I think that we continue to fool
ourselves. We look at the incidence of gonorrhea
as we say, "My goodness, twenty-five percent of the
patients with gonorrhea are under twenty years of
age," and then we forget about it. We come back
five years later and say, "My goodness, what are
these girls doing!"
Two days ago, the Richmond city newspapers
reported that 8 % of the girls at a local high school
are pregnant, and everyone looked at this with
amazement. Well, 8% of those girls have been pregnant for a long time. Seniors in high school are
sexually mature girls. I think we must accept
these facts . Once a girl has had intercourse for the
first time, be it at 14, 15, 16, or 18, she is not
going to revert.
Some people blame the current surge in the incidence of gonorrhea on birth control pills. They
say that when the condom was used there was a
lesser incidence. This is extremely difficult to prove;
I haven't seen any condom companies going out
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of business lately. It amazes me that a fair number
of adolescent women get birth control pills primarily because they don't want to get pregnant.
They would not, however, even consider carrying
condoms for the same protection. Condoms have
some effect in decreasing the spread of gonorrhea,
but would you be happy to rest back on condoms
for birth control? No one has been, so why should
you be satisfied with a condom as a means of controlling the spread of gonorrhea.
There is a current interest in antibiotic vaginal
cream. I have a great deal of trepidation about any
medication that is antibiotic and therefore antigenic
in nature that is persistently rubbed on a mucous
membrane. I think this would be an excellent way to
sensitize half the population of the country.
The limitations of public education must be
realized. The basic idea of alerting the public to the
inherent dangers of sexual contact is of academic
interest but hardly practical as policy. The increasing sales of tobacco should reinforce that point. It
may be of value to disseminate information about
the signs and symptoms of venereal disease because
it is likely to bring infected patients to medical attention, hopefully before they spread the disease.
This is particularly applicable to syphilis because it
has a long incubation period during which the patient is noninfectious and may be cured before
spreading the disease. Gonorrhea's short incubation
period, 4-10 days, makes it difficult for the physician
to get to the patient prior to the further spread of
the disease even under the best of circumstances.
At this point in time, the most intensive efforts
toward education should be made in the medical
schools. Very shortly these students will be faced
with large numbers of patients with venereal disease,
and we must prepare them. Unfortunately, this area
in the medical school curriculum has been progressively crowded out by what seemed more important.
It is now apparent that even though the prevalence
of venereal diseases may wax and wane, they will
always represent a sizable medical problem. We
must gear medical education and medical reeducation to meet these needs.
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